Thank you for your interest in the New Imaging Dementia—Evidence for Amyloid Scanning (New IDEAS) Study. After reviewing the New IDEAS protocol, please complete the feasibility questionnaire by clicking the link below that is applicable to your site’s role in patient care (either a Dementia Expert Site and/or a PET Imaging Facility). The 10-minute questionnaire will collect comprehensive information about your site, or facility, and the population you provide care for. After submission of the questionnaire, the study team will review all responses and provide you with a decision on your participation in the study via email. If your site or facility is invited to participate, you will be provided with all essential documents and further instructions on next steps and the start-up process.
Dementia practices and PET facility locations will be approved to participate on a rolling basis. The study team plans to have participating practices and facilities across the United States. Imaging facilities will need to be accessible to patients seeing the referring dementia experts and have access to one of the FDA-approved amyloid imaging agents.
The study plans to cap dementia practice participation at 350 locations. Once sites are selected, they will be listed on the New IDEAS study website. A committee led by the American College of Radiology® is responsible for site selection and will make final decisions based on feasibility questionnaire submissions.
The New IDEAS study is currently reaching out to dementia specialists in areas identified by our community engagement and recruitment team. If you have not been contacted yet and would like to be considered for inclusion in the study, please send an email to newideas@acr.org.
Participation in New IDEAS requires the submission of a site feasibility questionnaire and subsequent approval by the study. Information about the New IDEAS study will also be disseminated via professional organizations dedicated to neurology, psychiatry, geriatrics, nuclear medicine and radiology.
Access the feasibility questionnaire for referring dementia sites.
The New IDEAS study is currently reaching out to dementia specialists in areas identified by our community engagement and recruitment team. Those practices are asked to identify which imaging facility they would plan on referring their patients to. The study team will reach out to the imaging facilities that are identified. If you have not been contacted by the study and would like to be considered as a participating facility, please send an email to newideas@acr.org.
Participation in New IDEAS requires the submission of a site feasibility questionnaire and subsequent approval by the study. Information about the New IDEAS study will also be disseminated via professional organizations dedicated to neurology, psychiatry, geriatrics, nuclear medicine and radiology.
Access the feasibility questionnaire for imaging facilities.
No. Referring physician practices are required to apply for IRB approval via the central IRB (Advarra). PET facilities are NOT considered “engaged in research” and do not need to apply for IRB approval.
Please refer to the Institutional Review Board page of this website for instructions on how to obtain IRB approval.
Site agreements from either the PET facility or the referring physician practice should be scanned and emailed to newideas-contracts@acr.org. The agreements will be reviewed and countersigned. The fully executed agreement will be returned to the email address that submitted it. An MS Word version may be requested from the same email address.